PRGO
Perrigo Co. Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$16.09
−3.25%Oct 14, 2026, 22:45 UTC
The listed top gainers included Perrigo, up 3.77%; GILEAD SCIENCES, INC., up 3.8%; Kroger, up 3.87%; BRISTOL MYERS SQUIBB CO, up 4.61%; and UNITEDHEALTH GROUP INC, up 4.73%.
Source:Sep 25, 2026, 12:35 UTC
Perrigo (PRGO) shares rose 6.1% in the previous trading session on above-average volume.
Source:Aug 5, 2026, 10:30 UTC
Perrigo Company plc reported financial results from continuing operations for the second quarter ended June 27, 2026, highlighting market share growth in U.S. store-brand OTC and key European brands, completion of the Dermacosmetics divestiture, and reaffirmed full-year 2026 outlook.
Jul 30, 2026, 12:30 UTC
Perrigo Company plc announced a quarterly dividend of $0.29 per share, payable on September 15, 2026, to shareholders of record on August 28, 2026.
Source:Jun 30, 2026, 20:25 UTC
Perrigo Company plc appointed Salman Amin and Omer Gajial as independent directors to its Board, effective June 30, 2026.
Source:Jun 8, 2026, 20:18 UTC
Perrigo Company plc appointed Albert A. Manzone as Interim President and CEO, effective immediately, following the resignation of Patrick Lockwood-Taylor as President and CEO and as a board member.